We found that TBX2 subfamily has differential expression in Bladder Cancer (BLCA), Lung Adenocarcinoma (LUAD), Lung Squamous Cell Carcinoma (LUSC), Prostate Cancer (PRAD) and Sarcoma (SARC) compared to the matched normal tissues. This evidence concerns the gene TBX2 and Familial prostate cancer.